Ironvine Capital Partners, LLC Johnson & Johnson Transaction History

Ironvine Capital Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $2.36 Million - $2.53 Million	-14,818 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $378,542 - $524,489	3,406 Added 29.85%	14,818 $1.94 Million
Q4 2019 Jan 23, 2020	BUY	$127.5 - $146.44 $1.46 Million - $1.67 Million	11,412 New	11,412 $1.67 Million
Q4 2019 Jan 22, 2020	SELL	$127.5 - $146.44 $1.46 Million - $1.67 Million	-11,412 Closed	0 $0
Q3 2019 Oct 24, 2019	SELL	$126.95 - $142.14 $19,677 - $22,031	-155 Reduced 1.34%	11,412 $1.46 Million
Q2 2019 Jul 26, 2019	SELL	$131.15 - $144.24 $22,557 - $24,809	-172 Reduced 1.47%	11,567 $1.5 Million
Q1 2019 May 08, 2019	SELL	$125.72 - $139.79 $9.59 Million - $10.7 Million	-76,257 Reduced 86.66%	11,739 $1.64 Million
Q4 2018 Jan 30, 2019	BUY	$122.84 - $147.84 $1.47 Million - $1.77 Million	11,949 Added 15.71%	87,996 $11.4 Million
Q3 2018 Oct 29, 2018	BUY	$121.58 - $142.88 $78,662 - $92,443	647 Added 0.86%	76,047 $10.5 Million
Q2 2018 Jul 26, 2018	BUY	$119.4 - $131.76 $256,590 - $283,152	2,149 Added 2.93%	75,400 $9.15 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $2.61 Million - $3.09 Million	20,834 Added 39.75%	73,251 $9.39 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $6.88 Million - $7.53 Million	52,417	52,417 $7.32 Million

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Ironvine Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ironvine Capital Partners, LLC with notifications on news.